# Talisadi Churna

> Talisadi Churna is a classical Ayurvedic churna, a fine herbal powder. Listed in the Ayurvedic Formulary of India (AFI) Part I. Charaka Chikitsa Sthana 8/145-148. Sharangdhara Samhita, Madhyama Khanda 6/130-133. Essentially an extension of Sitopaladi Churna with the addition of Talisa (Abies webbiana) as the primary differentiating herb.

## Key facts

- **Pharmacopoeia status:** Listed in the Ayurvedic Formulary of India (AFI) Part I. Referenced in Sharangdhara Samhita official compendia. Recognized by AYUSH as a standard respiratory formulation.

## Names and identification

| Language | Name |
|----------|------|
| English | [Talisadi Churna](/formulation/talisadi-churna/) |

## Where is it described in the classical texts?

Charaka Chikitsa Sthana 8/145-148. Sharangdhara Samhita, Madhyama Khanda 6/130-133. Essentially an extension of [Sitopaladi Churna](/formulation/sitopaladi-churna/) with the addition of [Talisa](/herb/talisa/) (Abies webbiana) as the primary differentiating herb.

## How does it work?

- [Bronchodilator](/reference/bronchodilator/) action: [Piperine](/reference/piperine/) and volatile oils from [Talisa](/herb/talisa/) and [Pippali](/herb/pippali/) relax bronchial smooth muscle, improving airflow.
- Anti-inflammatory cytokine suppression: [Gingerol](/glossary/compounds-d-g/#gingerol) (from Shunthi) and piperine inhibit IL-6 and TNF-alpha, reducing respiratory tract inflammation.
- Mucolytic and [expectorant](/reference/expectorant/) activity: Reduces sputum viscosity and promotes expectoration, clearing respiratory passages.
- Bioavailability enhancement: Piperine enhances absorption of other active compounds ([cinnamaldehyde](/glossary/compounds-c-d/#cinnamaldehyde), cardamom essential oils).
- Digestive stimulation: [Trikatu](/herb/trikatu/) components kindle digestive fire (Agni), addressing the Ayurvedic principle that respiratory conditions often stem from impaired digestion.

## Which traditional uses are supported by research?

- Chronic bronchitis (validated by 12-week clinical trial with significant improvements in LCQ, SGRQ, and PEFR scores)
- Productive cough and sputum reduction (validated by pilot study showing reduced sputum viscosity in 2 weeks)
- Respiratory tract inflammation (validated by in vitro IL-6 and TNF-alpha inhibition studies)
- Digestive weakness associated with respiratory conditions (validated by carminative and digestive stimulant properties)

## What do recent clinical trials show?



*4 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.*

## Recent safety updates

- Likely safe and well-tolerated in most people within therapeutic dosage. Higher doses may cause burning sensation and gastritis due to hot potency of [Trikatu](/herb/trikatu/) ingredients.
- Contains approximately 70% sugar content (Sharkara); patients with diabetes or high blood sugar should consult physician before use.
- Some formulations may contain trace heavy metals (lead, mercury, arsenic); quality-tested products from reputable manufacturers recommended. Not recommended for prolonged unsupervised use.

## What is it made of?

### Key Active Markers

- Derived from constituent herbs (see individual herb profiles)
- Standardized on primary bioactive markers

**Analytical Methods:** HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

## Dosage forms and preparation

**Dosage Forms:** Churna (fine powder), Capsule, Tablet

**Standard Dosage:** 1-3g with honey

**Bioavailability:** Powder form provides faster disintegration than tablets; particle size reduction enhances surface area for absorption

**Optimal Timing:** Multiple times daily for respiratory conditions

**Shelf Life:** 2 years (as per ASU guidelines for churna)

**Storage:** Airtight container, cool dry place, protected from moisture

**Marker Compounds:** Piperine, Gingerol

**Quality Parameters:** Mesh size NLT 85#, moisture NMT 6%, total ash per pharmacopoeia, assay of marker compounds: Piperine, Gingerol

**Vehicle (Anupana):** Honey

### Synergistic Combinations

- With Honey as vehicle for enhanced absorption

---

Canonical version of this page: https://nighantu.ageayurveda.com/formulation/talisadi-churna/

## Sources

- Amidha Ayurveda Herb Database (700+ herbs, CC-BY-4.0)
- Web research (clinical trials, WHO monographs, safety databases)
- Ayurvedic Pharmacopoeia of India
- Classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita, Bhavaprakasha Nighantu)

Published by Age Ayurveda in the Nighantu. Educational reference only, not medical advice.
Incorporates material from the Amidha Ayurveda Herb Database under CC BY 4.0.